Designer Drugs: Hearing Before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-ninth Congress, First Session, on H.R. 2014, H.R. 2977, H.R. 3936, and S. 1437, May 1, 1986 |
From inside the book
Results 1-5 of 61
Page 10
... question that we are talking about . [ Video tape presentation : " The Walking Death . " ] Mr. HUGHES . I want to thank the gentleman from California for an excellent presentation . Congressman Charley Rangel is involved in a markup and ...
... question that we are talking about . [ Video tape presentation : " The Walking Death . " ] Mr. HUGHES . I want to thank the gentleman from California for an excellent presentation . Congressman Charley Rangel is involved in a markup and ...
Page 15
... psychotropic substances and what action including legislation DEA would recommend to control the problem . I will be pleased to answer any questions Members of the Subcommittee may have . Mr. HUGHES . I would like to welcome here this 15.
... psychotropic substances and what action including legislation DEA would recommend to control the problem . I will be pleased to answer any questions Members of the Subcommittee may have . Mr. HUGHES . I would like to welcome here this 15.
Page 21
... question that we need a strategy that includes education , demand reduction and treatment . It is disgrace- ful that in my own State alone , New Jersey , we have 10,000 hard core addicts walking around that want help , that need help ...
... question that we need a strategy that includes education , demand reduction and treatment . It is disgrace- ful that in my own State alone , New Jersey , we have 10,000 hard core addicts walking around that want help , that need help ...
Page 22
... question , Lawton , to you about what did or didn't take place in the Senate hearings . As I under- stand , we are going to have some complaints from people in re- search that the broader laws that you proposed and that are before us ...
... question , Lawton , to you about what did or didn't take place in the Senate hearings . As I under- stand , we are going to have some complaints from people in re- search that the broader laws that you proposed and that are before us ...
Page 23
... question because Mr. Lungren's bill is the Senate bill . My bill goes a little further ; it also deals with the Attorney Gener- al and asking that agency for a study of the precursor chemicals . I think it is not enough just to in fact ...
... question because Mr. Lungren's bill is the Senate bill . My bill goes a little further ; it also deals with the Attorney Gener- al and asking that agency for a study of the precursor chemicals . I think it is not enough just to in fact ...
Other editions - View all
Common terms and phrases
Administration amended amphetamine appropriate approved Attorney bill California Chairman chemical structure chemist clandestine laboratory Committee compounds conducted Congress controlled substance analogs Controlled Substances Act Cosmetic Act criminal Department of Health designer drug manufacture designer drug problem drug abuse Drug Enforcement Administration effect ELLINWOOD emergency scheduling exemption Federal Food fentanyl analogs fetus Florida Food and Drug going GRINSPOON HAWKS Health and Human heroin HUGHES human consumption Human Services human subjects identified illegal individual informed consent Institutional Review Board intended for human intent to distribute investigator law enforcement legislation legitimate research LUNGREN MCCOLLUM MDMA meperidine MPPP MPTP narcotic analogs NIDA paragraph Parkinson's disease potential produce programs psychoactive drugs public health regulations research activities research involving Senator CHILES specific statement statute street studies subpart substance in Schedules substantially similar Thank therapeutic tion Tocus toxicity trolled substance violation
Popular passages
Page 120 - Risks to subjects are reasonable in relation to anticipated benefits, if any, to subjects, and the importance of the knowledge that may reasonably be expected to result.
Page 122 - ... risks to the subject (or to the embryo or fetus, if the subject is or may become pregnant) which are currently unforeseeable; 2. anticipated circumstances under which the subject's participation may be terminated by the investigator without regard to the subject's consent; 3.
Page 119 - Each IRB shall have at least five members, with varying backgrounds to promote complete and adequate review of research activities commonly conducted by the institution. The IRB shall be sufficiently qualified through the experience and expertise of its members, and the diversity of the members...
Page 119 - IRB shall require documentation of informed consent or may waive documentation in accordance with §46.117. (d) An IRB shall notify investigators and the institution in writing of its decision to approve or disapprove the proposed research activity, or of modifications required to secure IRB approval of the research activity.
Page 25 - I would be pleased to respond to any questions you or members of the committee may have.
Page 128 - Requirements for permission by parents or guardians and for assent by children. (a) In addition to the determinations required under other applicable sections of this subpart. the IRB shall determine that adequate provisions are made for soliciting the assent of the children, when in the judgment of the IRB the children are capable of providing assent.
Page 121 - ... reports submitted by investigators, and reports of injuries to subjects. (2) Minutes of IRB meetings which shall be in sufficient detail to show attendance at the meetings; actions taken by the IRB; the vote on these actions including the number of members voting for, against, and abstaining; the basis for requiring changes in or disapproving research; and a written summary of the discussion of controverted issues and their resolution. (3) Records of continuing review activities. (4) Copies of...
Page 128 - Research not otherwise approvable which presents an opportunity to understand, prevent, or alleviate a serious problem affecting the health or welfare of children...
Page 119 - Except when an expedited review procedure is used (see § 46. 1 10), review proposed research at convened meetings at which a majority of the members of the IRB are present, including at least one member whose primary concerns are in nonscientific areas. In order for the research to be approved, it shall receive the approval of a majority of those members present at the meeting.